Blood Testing

Global Blood Testing Market to Reach US$143.1 Billion by 2030

The global market for Blood Testing estimated at US$93.3 Billion in the year 2024, is expected to reach US$143.1 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Glucose Testing, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$26.2 Billion by the end of the analysis period. Growth in the A1C Testing segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$25.4 Billion While China is Forecast to Grow at 11.4% CAGR

The Blood Testing market in the U.S. is estimated at US$25.4 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$29.9 Billion by the year 2030 trailing a CAGR of 11.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Blood Testing Market – Key Trends & Drivers Summarized

Why Is Blood Testing Becoming More Essential in Modern Healthcare?

Blood testing is one of the most fundamental diagnostic procedures in healthcare, providing critical insights into a patient’s overall health, disease status, and treatment response. From routine screenings to complex biomarker analysis, blood tests are used for diagnosing infections, metabolic disorders, cardiovascular diseases, cancers, and autoimmune conditions. The increasing prevalence of chronic diseases, rising awareness of preventive healthcare, and advancements in diagnostic technology have fueled the demand for blood testing in hospitals, diagnostic laboratories, and point-of-care settings.

The COVID-19 pandemic further highlighted the importance of rapid and accurate blood testing, leading to increased investments in diagnostic infrastructure and the adoption of advanced technologies, such as PCR-based and serological tests. Additionally, personalized medicine and precision diagnostics have expanded the role of blood testing in guiding targeted therapies, particularly in oncology and genetic disorders. As healthcare systems continue to shift toward early disease detection and preventive care, the demand for fast, accurate, and minimally invasive blood testing solutions is expected to rise significantly.

How Are Technological Advancements Transforming Blood Testing?

Significant innovations in blood testing technology are enhancing accuracy, speed, and convenience, making diagnostics more accessible to patients and healthcare providers. One of the most transformative advancements in this field is the development of liquid biopsy technology, which enables the detection of cancer and other diseases through circulating tumor DNA (ctDNA) and biomarkers in the blood. Liquid biopsies offer a non-invasive alternative to traditional tissue biopsies, allowing for early cancer detection, disease monitoring, and treatment response evaluation.

Another breakthrough in blood testing is the emergence of point-of-care (POC) and home-based blood testing devices. These portable and user-friendly systems enable rapid testing for glucose, cholesterol, infectious diseases, and coagulation levels without requiring a full laboratory setup. Additionally, artificial intelligence (AI) and machine learning (ML) are being integrated into diagnostic platforms to enhance test interpretation, improve predictive analytics, and reduce diagnostic errors. The adoption of microfluidic and lab-on-a-chip technologies has also streamlined sample processing, enabling rapid and automated blood analysis with minimal sample volumes. As these technological advancements continue to evolve, they are revolutionizing the blood testing landscape, making diagnostics faster, more precise, and increasingly patient-centric.

Which Market Trends Are Driving Growth in the Blood Testing Industry?

The growing emphasis on preventive healthcare and routine screening is one of the most influential trends driving the blood testing market. With a rise in lifestyle-related conditions such as diabetes, cardiovascular diseases, and liver disorders, more individuals are undergoing regular blood tests for early detection and risk assessment. The increasing availability of direct-to-consumer (DTC) blood testing services, where individuals can order tests online without a physician’s referral, is also fueling market expansion. These services offer at-home sample collection and digital result interpretation, providing greater convenience and accessibility for health-conscious consumers.

Another key trend shaping the market is the expansion of genetic and biomarker-based blood tests. As precision medicine gains traction, blood testing is being used to identify genetic predispositions to diseases, guide targeted treatments, and monitor disease progression. Additionally, the rise of telemedicine and remote patient monitoring has accelerated the adoption of connected blood testing devices that sync with digital health platforms, enabling real-time tracking and physician consultations. The growing global focus on infectious disease surveillance, including emerging threats such as antimicrobial resistance, is also driving demand for rapid and high-throughput blood testing solutions.

What Are the Key Growth Drivers Shaping the Future of the Blood Testing Market?

The growth in the blood testing market is driven by several critical factors, including rising disease prevalence, advancements in diagnostic technology, and increasing healthcare investments. One of the primary growth drivers is the rising incidence of chronic and infectious diseases, which has led to an increased need for early and accurate diagnosis. Governments and healthcare organizations worldwide are prioritizing disease prevention and early intervention, leading to greater adoption of routine blood testing for population health management.

Another crucial driver shaping the market is the increasing shift toward decentralized and at-home testing solutions. As consumers demand greater convenience and accessibility, diagnostic companies are investing in portable, user-friendly blood testing devices that provide rapid results without the need for laboratory visits. Additionally, advancements in data analytics and AI-driven diagnostics are enhancing test accuracy, enabling personalized risk assessments and predictive modeling for various diseases. As the global healthcare landscape continues to evolve, the blood testing market is expected to expand, driven by innovation, increasing health awareness, and the continuous pursuit of more efficient, cost-effective diagnostic solutions.

SCOPE OF STUDY:

The report analyzes the Blood Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Test Type (Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing, Thyroid-stimulating Hormone (TSH) Testing, Serum Nicotine/Cotinine Testing, High sensitivity CRP Testing, Testosterone Testing, ALT Testing, Cortisol Testing, Creatinine Testing, AST Testing, Others Blood Tests)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• Abbott Laboratories
• ARUP Laboratories
• Beckman Coulter
• Becton, Dickinson and Company (BD)
• Bio-Rad Laboratories
• Cepheid
• Charles River Laboratories
• Eurofins Scientific
• Genomic Health
• Illumina
• Labcorp (Laboratory Corp of America)
• Myriad Genetics
• Natera
• PerkinElmer
• Qiagen
• Quest Diagnostics
• Roche Diagnostics
• Siemens Healthineers
• Sonic Healthcare
• Thermo Fisher Scientific

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.